GIAN PAOLO FADINI

Full Professor

University of Padova

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Gian Paolo Fadini is a Full Professor at the University of Padova, Italy. His research encompasses various aspects of diabetes management, including cardiovascular protection, kidney function preservation, and the impact of sex on weight responses to GLP-1 receptor agonists. He has contributed to significant studies on diabetes treatment effectiveness using real-world data and machine learning models. His work aims to enhance understanding and management strategies for type 2 diabetes and its complications.

Articles (29)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (14)

Stefano Ciciliot

Assistant Professor

University of Pavia

ITALY

View details

Guillermo Umpierrez

Professor of Medicine

Emory University School of Medicine

UNITED STATES

View details

Rozalina McCoy

Associate Professor of Medicine

University of Maryland School of Medicine

UNITED STATES

View details

Shivshankar Thanigaimani

AUSTRALIA

View details

Jonathan Golledge

College of Medicine and Dentistry

AUSTRALIA

View details

Mattia Albiero

Assistant Professor

University of Padova

ITALY

View details

Rodolfo Galindo

Associate Professor

University of Miami Miller School of Medicine

UNITED STATES

View details

Maria Gisella Cavallo

Sapienza University

ITALY

View details

Ilaria Barchetta

Assistant Professor (Tenure track)

Sapienza University of Rome

ITALY

View details

Angelo Avogaro

ITALY

View details

Nikolaos Tentolouris

Professor, Head of the Diabetes Center

National and Kapodistrian University of Athens

GREECE

View details

Raffaella Buzzetti

ITALY

View details

Shivani Misra

Wellcome Trust Career Development Fellow (Senior Clinical Lecturer)

Imperial College London

UNITED KINGDOM

View details

Enrico Longato

University of Padua

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

GIAN PAOLO FADINI

Research Interests

Explore related searches

Contact this professor

About

Articles (29)

The impact of clinical history on the predictive performance of machine learning and deep learning models for renal complications of diabetes

Can Dual Incretin Receptor Agonists Exert Better Cardiovascular Protection than Selective GLP-1 Receptor Agonists? Highlights from SURPASS-CVOT

Effectiveness of oral semaglutide versus empagliflozin for the management of type 2 diabetes. PIONEER‐2 trial emulation with real‐world data

Long‐term preservation of kidney function with SGLT‐2 inhibitors versus comparator drugs in people with type 2 diabetes and chronic kidney disease

Sex differences in the weight response to GLP-1RA in people with type 2 diabetes. A long-term longitudinal real-world study

The Clock is Still Ticking: Tirzepatide and the Myth of Halting the Natural History of Type 2 Diabetes

Early weight loss, diabetes remission and long-term trajectory after diagnosis of type 2 diabetes: a retrospective study

Oncostatin M is dispensable for the regulation of hematopoietic stem/progenitor cell traffic by neutrophils

Preferences, Expectations and Attitudes on Basal Insulin from Patient–Physician–Payer Perspective: A Multi-stakeholder Survey by the Italian Diabetes Society (ITA4P Study)

Long-term effects of adding an SGLT-2 inhibitor to insulin therapy in patients with type 1 diabetes. An observational study and systematic review of real-world evidence

IDegLira for the real‐world treatment of type 2 diabetes in Italy. Final results from the REX observational study

Hyperglycemic Crises in Adults With Diabetes: A Consensus Report

Hyperglycaemic crises in adults with diabetes: a consensus report

Suitability and Usefulness of a Flexible Dosing Timing of Oral Semaglutide to Maximize Benefit in Clinical Practice: An Expert Panel

The Elusive Nature of ABCC8-related Maturity-Onset Diabetes of the Young (ABCC8-MODY). A Review of the Literature and Case Discussion

Comparative renal outcomes of matched cohorts of patients with type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists under routine care

Oral or injectable semaglutide for the management of type 2 diabetes in routine care: A multicentre observational study comparing matched cohorts

Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk

Vitamin D and Cardiovascular Risk

Loss of Hematopoietic Cell-Derived Oncostatin M Worsens Diet-Induced Dysmetabolism in Mice.

Safety of sodium‐glucose cotransporter 2 inhibitors in elderly patients with type 2 diabetes: A meta‐analysis of randomized controlled trials

Improved prediction of long-term kidney outcomes in people with type 2 diabetes by levels of circulating haematopoietic stem/progenitor cells

Recent developments in targets for ischemic foot disease

Putative circulating adipose tissue-derived stem cells, obesity, and metabolic syndrome features

Deciphering dementia in the cardiometabolic continuum

Short-term effectiveness of dapagliflozin versus DPP-4 inhibitors in elderly patients with type 2 diabetes: a multicentre retrospective study

Efficacy of Dapagliflozin in Southern Europe Across the Spectrum of Characteristics of Type 2 Diabetes: An International Real-World Analysis

Management of type 2 diabetes with a treat-to-benefit approach improved long-term cardiovascular outcomes under routine care

The Fast-Glycator Phenotype, Skin Advanced Glycation End Products, and Complication Burden Among People With Type 1 Diabetes

Collaborators (14)

Stefano Ciciliot

Guillermo Umpierrez

Rozalina McCoy

Shivshankar Thanigaimani

Jonathan Golledge

Mattia Albiero

Rodolfo Galindo

Maria Gisella Cavallo

Ilaria Barchetta

Angelo Avogaro

Nikolaos Tentolouris

Raffaella Buzzetti

Shivani Misra

Enrico Longato

Make your next move.